DIGESTIVE REDS

Serial Number 97784098
600

Registration Progress

Application Filed
Feb 7, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Basic Information

Serial Number
97784098
Filing Date
February 7, 2023
Abandonment Date
August 6, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
600
Status Date
Aug 18, 2024
Classes
005

Rights Holder

Biohm Health Inc.

03
Address
425 Literary Road, Suite 100
Cleveland, OH 44113

Ownership History

Biohm Health Inc.

Original Applicant
03
Cleveland, OH

Legal Representation

Attorney
Brian E Turung
USPTO Deadlines 0 active
All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

16 events
Date Code Type Description
Aug 18, 2024 MAB0 E ABANDONMENT NOTICE E-MAILED - INCOMPLETE RESPONSE
Aug 5, 2024 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 5, 2024 ABN0 O ABANDONMENT - INCOMPLETE RESPONSE
Aug 5, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 5, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 5, 2024 CNFR R FINAL REFUSAL WRITTEN
May 5, 2024 GNFR O FINAL REFUSAL E-MAILED
May 5, 2024 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Feb 26, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 26, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 25, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 25, 2023 GNRT F NON-FINAL ACTION E-MAILED
Nov 25, 2023 CNRT R NON-FINAL ACTION WRITTEN
Nov 4, 2023 DOCK D ASSIGNED TO EXAMINER
Apr 26, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 005
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; dietary supplements for medical use, namely, metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; fungal extracts sold as a component ingredient of nutritional supplements and vitamins and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's disease, ulcerative colitis and irritable bowel syndrome

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"REDS"